{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T09:20:39Z","timestamp":1794043239059,"version":"4.8.0"},"reference-count":162,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["ACAMC"],"published-print":{"date-parts":[[2019,5,8]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Cancer continues to be one of the major causes of death worldwide. Despite many advances in the\nunderstanding of this complex disease, new approaches are needed to improve the efficacy of current therapeutic\ntreatments against aggressive tumors. Natural products are one of the most consistently successful sources of drug\nleads. In recent decades, research activity into the clinical potential of this class of compounds in cancer has\nincreased. Furthermore, a highly promising field is the use of metals and their complexes in the design and\ndevelopment of metal-based drugs for the treatment of cancer. Metal complexes offer unique opportunities due to\ntheir ability to alter pharmacology, improving the efficacy and\/or reducing the negative side effects of drug\nmolecules. In addition, transition metals as copper, iron, and manganese, among others, can interact with active\nsites of enzymes, playing important roles in multiple biological processes. Thus, these complexes not only possess\nhigher activities but also reach their targets more efficiently. This review article highlights recent advances on the\nemerging and expanding field of metal-based drugs. The emphasis is on new therapeutic strategies consisting of\nmetal complexes with natural product like-compounds as a starting point for the rational design of new antitumor\nagents.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871520618666180420165821","type":"journal-article","created":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T12:02:47Z","timestamp":1524657767000},"page":"48-65","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Metal Complexes of Natural Product Like-compounds with Antitumor Activity"],"prefix":"10.2174","volume":"19","author":[{"given":"Beatriz L.","family":"Heras","sequence":"first","affiliation":[{"name":"Departamento de Farmacologia. Facultad de Farmacia, Universidad Complutense de Madrid (UCM), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"Amesty","sequence":"additional","affiliation":[{"name":"Departamento de Quimica Organica, Instituto Universitario de Bio-Organica Antonio Gonzalez, Universidad de La Laguna. Avda. Astrofisico Fco. Sanchez 2. 38206. La Laguna, Tenerife, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Est\u00e9vez-Braun","sequence":"additional","affiliation":[{"name":"Departamento de Quimica Organica, Instituto Universitario de Bio-Organica Antonio Gonzalez, Universidad de La Laguna. Avda. Astrofisico Fco. Sanchez 2. 38206. La Laguna, Tenerife, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonsoles","family":"Hortelano","sequence":"additional","affiliation":[{"name":"Unidad de Terapias Farmacologicas. Area de Genetica Humana. Instituto de Investigacion de Enfermedades Raras (IIER), Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","volume":"79","author":"Newman D.J.","year":"2016","unstructured":"Newman DJ, Cragg GM. J Nat Prod, Natural Products as sources of new drugs from 1981 to 2014.,, 2016, 79,, 629-661,","journal-title":"J Nat Prod"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.2174\/138161210791209009","volume":"16","author":"Frezza M.","year":"2010","unstructured":"Frezza M, Hindo S, Chen D, Davenport A, Schmitt S, Tomco D, Dou QP. Curr Pharm Des, Novel metals and metal complexes as platforms for cancer therapy.,, 2010, 16,, 1813-1825,","journal-title":"Curr Pharm Des"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.cbpa.2007.05.013","volume":"11","author":"Meggers E.","year":"2007","unstructured":"Meggers E. Curr Opin Chem Biol, Exploring biologically relevant chemical space with metal complexes.,, 2007, 11,, 287-292,","journal-title":"Curr Opin Chem Biol"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","volume":"7","author":"Kelland L.","year":"2007","unstructured":"Kelland L. Nat Rev Cancer, The resurgence of platinum-based cancer chemotherapy.,, 2007, 7,, 573-584,","journal-title":"Nat Rev Cancer"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/med.10038","volume":"23","author":"Ho Y-P.","year":"2003","unstructured":"Ho Y-P, Au-Yeung SCF, To KKW. Med Res Rev, Platinum-based anticancer agents: Innovative design strategies and biological perspectives.,, 2003, 23,, 633-655,","journal-title":"Med Res Rev"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"20309","DOI":"10.1039\/C4RA13547D","volume":"5","author":"Wellington K.W.","year":"2015","unstructured":"Wellington KW. RSC Adv, Understanding cancer and the anticancer activities of naphthoquinones - a review.,, 2015, 5,, 20309-20338,","journal-title":"RSC Adv"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jphs.2017.04.003","volume":"134","author":"Chen G.","year":"2017","unstructured":"Chen G, Yue Y, Qin J, Xiao X, Ren Q, Xiao B. J Pharmacol Sci, Plumbagin suppresses the migration and invasion of glioma cells via downregulation of MMP-2\/9 expression and inaction of PI3K\/Akt signaling pathway in vitro.,, 2017, 134,, 59-67,","journal-title":"J Pharmacol Sci"},{"key":"ref=8","first-page":"783","volume":"18","author":"Hisa T.","year":"1998","unstructured":"Hisa T, Kimura Y, Takada K, Suzuki F, Takigawa M. Anticancer Res, Shikonin, an ingredient of lithospermum erythrorhizon, inhibits angiogenesis in vivo and in vitro.,, 1998, 18,, 783-790,","journal-title":"Anticancer Res"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1002\/ijc.22486","volume":"120","author":"Lee H.J.","year":"2007","unstructured":"Lee HJ, Lee H-J, Song G-Y, Li G, Lee J-H, L\u00fc J, Kim S-H. Int J Cancer, 6-(1-Oxobutyl)-5,8-dimethoxy-1,4-naphthoquinone inhibits lewis lung cancer by antiangiogenesis and apoptosis.,, 2007, 120,, 2481-2490,","journal-title":"Int J Cancer"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bcp.2017.10.008","volume":"146","author":"Hamdoun S.","year":"2017","unstructured":"Hamdoun S, Fleischer E, Klinger A, Efferth T. Biochem Pharmacol, Lawsone derivatives target the Wnt\/\u03b2-catenin signaling pathway in multidrug-resistant acute lymphoblastic leukemia cells.,, 2017, 146,, 63-73,","journal-title":"Biochem Pharmacol"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.biopha.2017.01.169","volume":"89","author":"Wang S.B.","year":"2017","unstructured":"Wang SB, Tao Z, Li P. Biomed Pharmacother, Lawsone suppresses azoxymethane mediated colon cancer in rats and reduces proliferation of DLD-1 cells via NF-kappaB pathway.,, 2017, 89,, 152-161,","journal-title":"Biomed Pharmacother"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.bmc.2013.03.002","volume":"21","author":"Oramas-Royo S.","year":"2013","unstructured":"Oramas-Royo S, Torrej\u00f3n C, Cuadrado I, Hern\u00e1ndez-Molina R, Hortelano S, Est\u00e9vez-Braun A, de las Heras B. Bioorg Med Chem, Synthesis and cytotoxic activity of metallic complexes of lawsone.,, 2013, 21,, 2471-2477,","journal-title":"Bioorg Med Chem"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1155\/MBD.2000.121","volume":"7","author":"Gokhale N.","year":"2000","unstructured":"Gokhale N, Padhye S, Newton C, Pritchard R. Met Based Drugs, Hydroxynaphthoquinone metal complexes as antitumor agents x: synthesis, structure, spectroscopy and in vitro antitumor activity of 3-methyl-phenylazo lawsone derivatives and their metal complexes against human breast cancer cell line MCF-7.,, 2000, 7,, 121-128,","journal-title":"Met Based Drugs"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1049\/iet-nbt.2015.0008","volume":"9","author":"Appadurai P.","year":"2015","unstructured":"Appadurai P, Rathinasamy K. IET Nanobiotechnol, Plumbagin-silver nanoparticle formulations enhance the cellular uptake of plumbagin and its antiproliferative activities.,, 2015, 9,, 264-272,","journal-title":"IET Nanobiotechnol"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jinorgbio.2014.04.020","volume":"138","author":"Spoerlein-Guettler C.","year":"2014","unstructured":"Spoerlein-Guettler C, Mahal K, Schobert R, Biersack B. J Inorg Biochem, Ferrocene and (arene)ruthenium(II) complexes of the natural anticancer naphthoquinone plumbagin with enhanced efficacy against resistant cancer cells and a genuine mode of action.,, 2014, 138,, 64-72,","journal-title":"J Inorg Biochem"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jinorgbio.2010.12.003","volume":"105","author":"Chen Z-F.","year":"2011","unstructured":"Chen Z-F, Tan M-X, Liu Y-C, Peng Y, Wang H-H, Liu H-G, Liang H. J Inorg Biochem, Synthesis, characterization and preliminary cytotoxicity evaluation of five Lanthanide(III)\u2013Plumbagin complexes.,, 2011, 105,, 426-434,","journal-title":"J Inorg Biochem"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jinorgbio.2015.09.004","volume":"153","author":"Gou Y.","year":"2015","unstructured":"Gou Y, Zhang Z, Qi J, Liang S, Zhou Z, Yang F, Liang H. J Inorg Biochem, Folate-functionalized human serum albumin carrier for anticancer copper(II) complexes derived from natural plumbagin.,, 2015, 153,, 13-22,","journal-title":"J Inorg Biochem"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1039\/c3cc40432c","volume":"49","author":"Kandioller W.","year":"2013","unstructured":"Kandioller W, Balsano E, Meier SM, Jungwirth U, Goschl S, Roller A, Jakupec MA, Berger W, Keppler BK, Hartinger CG. Chem Commun, Organometallic anticancer complexes of lapachol: metal centre-dependent formation of reactive oxygen species and correlation with cytotoxicity.,, 2013, 49,, 3348-3350,","journal-title":"Chem Commun"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0020-1693(03)00484-5","volume":"357","author":"Afrasiabi Z.","year":"2004","unstructured":"Afrasiabi Z, Sinn E, Chen J, Ma Y, Rheingold AL, Zakharov LN, Rath N, Padhye S. Inorg Chim Acta, Appended 1,2-naphthoquinones as anticancer agents 1: Synthesis, structural, spectral and antitumor activities of ortho-naphthaquinone thiosemicarbazone and its transition metal complexes.,, 2004, 357,, 271-278,","journal-title":"Inorg Chim Acta"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.jinorgbio.2005.04.012","volume":"99","author":"Afrasiabi Z.","year":"2005","unstructured":"Afrasiabi Z, Sinn E, Lin W, Ma Y, Campana C, Padhye S. J Inorg Biochem, Nickel (II) complexes of naphthaquinone thiosemicarbazone and semicarbazone: Synthesis, structure, spectroscopy, and biological activity.,, 2005, 99,, 1526-1531,","journal-title":"J Inorg Biochem"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jinorgbio.2012.10.007","volume":"119","author":"Neves A.P.","year":"2013","unstructured":"Neves AP, Pereira MXG, Peterson EJ, Kipping R, Vargas MD, Silva-Jr FP, Carneiro JWM, Farrell NP. J Inorg Biochem, Exploring the DNA binding\/cleavage, cellular accumulation and topoisomerase inhibition of 2-hydroxy-3-(aminomethyl)-1,4-naphthoquinone mannich bases and their platinum(II) complexes.,, 2013, 119,, 54-64,","journal-title":"J Inorg Biochem"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s10534-016-9970-0","volume":"29","author":"Tabrizi L.","year":"2016","unstructured":"Tabrizi L, Fooladivanda M, Chiniforoshan H. Biometals, Copper(II), cobalt(II) and nickel(II) complexes of juglone: Synthesis, structure, DNA interaction and enhanced cytotoxicity.,, 2016, 29,, 981-993,","journal-title":"Biometals"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/med.21391","volume":"36","author":"Malik E.M.","year":"2016","unstructured":"Malik EM, M\u00fcller CE. Med Res Rev, Anthraquinones as pharmacological tools and drugs.,, 2016, 36,, 705-748,","journal-title":"Med Res Rev"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.7326\/0003-4819-105-1-67","volume":"105","author":"Shenkenberg T.D.","year":"1986","unstructured":"Shenkenberg TD, Von Hoff DD. Ann Intern Med, Mitoxantrone: A new anticancer drug with significant clinical activity.,, 1986, 105,, 67-81,","journal-title":"Ann Intern Med"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/med.21364","volume":"36","author":"Evison B.J.","year":"2016","unstructured":"Evison BJ, Sleebs BE, Watson KG, Phillips DR, Cutts SM. Med Res Rev, Mitoxantrone, more than just another topoisomerase ii poison.,, 2016, 36,, 248-299,","journal-title":"Med Res Rev"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"115287","DOI":"10.1371\/journal.pone.0115287","volume":"9","author":"Guerriero E.","year":"2014","unstructured":"Guerriero E, Sorice A, Capone F, Napolitano V, Colonna G, Storti G, Castello G, Costantini S. PLoS One, Vitamin C effect on mitoxantrone-induced cytotoxicity in human breast cancer cell lines.,, 2014, 9,, e115287-,","journal-title":"PLoS One"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0304-4165(87)90210-8","volume":"926","author":"Kolodziejczyk P.","year":"1987","unstructured":"Kolodziejczyk P, Garnier-Suillerot A. Biochim Biophys Acta, Circular dichroism study of the interaction of mitoxantrone, ametantrone and their Pd(II) complexes with deoxyribonucleic acid.,, 1987, 926,, 249-257,","journal-title":"Biochim Biophys Acta"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0162-0134(92)80045-W","volume":"45","author":"Pettit L.D.","year":"1992","unstructured":"Pettit LD, Ueda J-I, Morier-Teissier E, Helbecque N, Bernier J-L, Henichart J-P, Kozlowski H. J Inorg Biochem, The coordination of copper(II) to 1-hydroxy-4-(glycyl-histidyl-lysine)-anthraquinone; A synthetic model of anthraquinone anti-cancer drugs.,, 1992, 45,, 203-210,","journal-title":"J Inorg Biochem"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1021\/jm00067a005","volume":"36","author":"Morier-Teissier E.","year":"1993","unstructured":"Morier-Teissier E, Boitte N, Helbecque N, Bernier JL, Pommery N, Duvalet JL, Fournier C, Hecquet B, Catteau JP, Henichart JP. J Med Chem, Synthesis and antitumor properties of an anthraquinone bisubstituted by the copper chelating peptide Gly-Gly-L-His.,, 1993, 36,, 2084-2090,","journal-title":"J Med Chem"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"9699","DOI":"10.1039\/c3dt50865j","volume":"42","author":"Du S.","year":"2013","unstructured":"Du S, Feng J, Lu X, Wang G. Dalton Trans, The syntheses and characterizations of vanadium complexes with 1,2-dihydroxyanthraquinone and the structure-effect relationship in their in vitro anticancer activities.,, 2013, 42,, 9699-9705,","journal-title":"Dalton Trans"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00775-011-0831-6","volume":"17","author":"Kou J-F.","year":"2012","unstructured":"Kou J-F, Qian C, Wang J-Q, Chen X, Wang L-L, Chao H, Ji L-N. J Biol Inorg Chem, Chiral ruthenium(II) anthraquinone complexes as dual inhibitors of topoisomerases I and II.,, 2012, 17,, 81-96,","journal-title":"J Biol Inorg Chem"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"f539","DOI":"10.1152\/ajpcell.00047.2010","volume":"299","author":"Griffin M.O.","year":"2010","unstructured":"Griffin MO, Fricovsky E, Ceballos G, Villarreal F. Am J Physiol Cell Physiol, Tetracyclines: A pleitropic family of compounds with promising therapeutic properties. Review of the literature.,, 2010, 299,, C539-C548,","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaad.2005.10.004","volume":"54","author":"Sapadin A.N.","year":"2006","unstructured":"Sapadin AN, Fleischmajer R. J Am Acad Dermatol, Tetracyclines: Nonantibiotic properties and their clinical implications.,, 2006, 54,, 258-265,","journal-title":"J Am Acad Dermatol"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/jnci\/93.3.178","volume":"93","author":"Hidalgo M.","year":"2001","unstructured":"Hidalgo M, Eckhardt SG. J Natl Cancer Inst, Development of matrix metalloproteinase inhibitors in cancer therapy.,, 2001, 93,, 178-193,","journal-title":"J Natl Cancer Inst"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1067\/mlc.2001.116591","volume":"138","author":"Rubins J.B.","year":"2001","unstructured":"Rubins JB, Charboneau D, Alter MD, Bitterman PB, Kratzke RA. J Lab Clin Med, Inhibition of mesothelioma cell growth in vitro by doxycycline.,, 2001, 138,, 101-106,","journal-title":"J Lab Clin Med"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"6414","DOI":"10.1021\/ic101791r","volume":"50","author":"Silva P.P.","year":"2011","unstructured":"Silva PP, Guerra W, Silveira JN, Ferreira AMDC, Bortolotto T, Fischer FL, Terenzi H, Neves A, Pereira-Maia EC. Inorg Chem, Two new ternary complexes of copper(ii) with tetracycline or doxycycline and 1,10-phenanthroline and their potential as antitumoral: Cytotoxicity and DNA cleavage.,, 2011, 50,, 6414-6424,","journal-title":"Inorg Chem"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0141-8130(03)00066-7","volume":"33","author":"Khan M.A.","year":"2003","unstructured":"Khan MA, Musarrat J. Int J Biol Macromol, Interactions of tetracycline and its derivatives with DNA in vitro in presence of metal ions.,, 2003, 33,, 49-56,","journal-title":"Int J Biol Macromol"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0027-5107(03)00008-3","volume":"525","author":"Khan M.A.","year":"2003","unstructured":"Khan MA, Mustafa J, Musarrat J. Mutat Res, Mechanism of DNA strand breakage induced by photosensitized tetracycline\u2013Cu(II) complex.,, 2003, 525,, 109-119,","journal-title":"Mutat Res"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1590\/S0103-50532010000700011","volume":"21","author":"Silva P.P.","year":"2010","unstructured":"Silva PP, Paula FCSD, Guerra W, Silveira JN, Botelho FV, Vieira LQ, Bortolotto T, Fischer FL, Bussi G, Terenzi H, Pereira-Maia EC. J Braz Chem Soc, Platinum(II) compounds of tetracyclines as potential anticancer agents: Cytotoxicity, uptake and interactions with DNA.,, 2010, 21,, 1237-1246,","journal-title":"J Braz Chem Soc"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"10330","DOI":"10.1039\/C5DT00770D","volume":"44","author":"Yousuf I.","year":"2015","unstructured":"Yousuf I, Arjmand F, Tabassum S, Toupet L, Khan RA, Siddiqui MA. Dalton Trans, Mechanistic insights into a novel chromone-appended Cu(II) anticancer drug entity: In vitro binding profile with DNA\/RNA substrates and cytotoxic activity against MCF-7 and HepG2 cancer cells.,, 2015, 44,, 10330-10342,","journal-title":"Dalton Trans"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jscs.2013.03.005","volume":"20","author":"Kavitha P.","year":"2016","unstructured":"Kavitha P, Rama Chary M, Singavarapu BVVA, Laxma Reddy K. J Saudi Chem Soc, Synthesis, characterization, biological activity and DNA cleavage studies of tridentate Schiff bases and their Co(II) complexes.,, 2016, 20,, 69-80,","journal-title":"J Saudi Chem Soc"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.molstruc.2016.03.060","volume":"1118","author":"Saif M.","year":"2016","unstructured":"Saif M, El-Shafiy HF, Mashaly MM, Eid MF, Nabeel AI, Fouad R. J Mol Struct, Synthesis, characterization, and antioxidant\/cytotoxic activity of new chromone Schiff base nano-complexes of Zn(II), Cu(II), Ni(II) and Co(II).,, 2016, 1118,, 75-82,","journal-title":"J Mol Struct"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11243-014-9904-z","volume":"40","author":"Elsayed S.A.","year":"2015","unstructured":"Elsayed SA, Butler IS, Claude BJ, Mostafa SI. Trans Met Chem, Synthesis, characterization and anticancer activity of 3-formylchromone benzoylhydrazone metal complexes.,, 2015, 40,, 179-187,","journal-title":"Trans Met Chem"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2174\/092986710790936284","volume":"17","author":"Riveiro M.E.","year":"2010","unstructured":"Riveiro ME, Kimpe ND, Moglioni A, Vazquez R, Monczor F, Shayo C, Davio C. Curr Med Chem, Coumarins: Old compounds with novel promising therapeutic perspectives.,, 2010, 17,, 1325-1338,","journal-title":"Curr Med Chem"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jinorgbio.2015.01.006","volume":"145","author":"Klepka M.T.","year":"2015","unstructured":"Klepka MT, Drzewiecka-Antonik A, Wolska A, Rejmak P, Ostrowska K, Hejchman E, Kruszewska H, Czajkowska A, M\u0142ynarczuk-Bia\u0142y I, Ferenc W. J Inorg Biochem, Synthesis, structural studies and biological activity of new Cu(II) complexes with acetyl derivatives of 7-hydroxy-4-methylcoumarin.,, 2015, 145,, 94-100,","journal-title":"J Inorg Biochem"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/cbdd.12418","volume":"85","author":"Zhu T.","year":"2015","unstructured":"Zhu T, Wang Y, Ding W, Xu J, Chen R, Xie J, Zhu W, Jia L, Ma T. Chem Biol Drug Des, Anticancer activity and DNA-binding investigations of the Cu(II) and Ni(II) complexes with coumarin derivative.,, 2015, 85,, 385-393,","journal-title":"Chem Biol Drug Des"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejphar.2007.04.064","volume":"569","author":"Thati B.","year":"2007","unstructured":"Thati B, Noble A, Creaven BS, Walsh M, Kavanagh K, Egan DA. Eur J Pharmacol, Apoptotic cell death: A possible key event in mediating the in vitro anti-proliferative effect of a novel copper(II) complex, [Cu(4-Mecdoa) (phen)(2)] (phen=phenanthroline, 4-Mecdoa=4-methylcoumarin-6,7-dioxactetate), in human malignant cancer cells.,, 2007, 569,, 16-28,","journal-title":"Eur J Pharmacol"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cbi.2007.04.003","volume":"168","author":"Thati B.","year":"2007","unstructured":"Thati B, Noble A, Creaven BS, Walsh M, Kavanagh K, Egan DA. Chem Biol Interact, An in vitro investigation of the induction of apoptosis and modulation of cell cycle events in human cancer cells by bisphenanthroline-coumarin-6,7-dioxacetatocopper(II) complex.,, 2007, 168,, 143-158,","journal-title":"Chem Biol Interact"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.3892\/mmr.2014.2519","volume":"10","author":"Zhu T.","year":"2014","unstructured":"Zhu T, Chen R, Yu H, Feng Y, Chen J, Lu Q, Xie J, Ding W, Ma T. Mol Med Rep, Antitumor effect of a copper (II) complex of a coumarin derivative and phenanthroline on lung adenocarcinoma cells and the mechanism of action.,, 2014, 10,, 2477-2482,","journal-title":"Mol Med Rep"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1016\/j.ejmech.2008.02.013","volume":"43","author":"Bagihalli G.B.","year":"2008","unstructured":"Bagihalli GB, Avaji PG, Patil SA, Badami PS. Eur J Med Chem, Synthesis, spectral characterization, in vitro antibacterial, antifungal and cytotoxic activities of Co(II), Ni(II) and Cu(II) complexes with 1,2,4-triazole Schiff bases.,, 2008, 43,, 2639-2649,","journal-title":"Eur J Med Chem"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1248\/cpb.58.1003","volume":"58","author":"Jia L.","year":"2010","unstructured":"Jia L, Xu X-M, Xu J, Chen L-H, Jiang P, Cheng F-X, Lu G-N, Wang Q, Wu J-C, Tang N. Chem Pharm Bull, Synthesis, characterization, cytotoxic activities, and DNA-binding studies of ternary copper(ii) complexes with new coumarin derivatives.,, 2010, 58,, 1003-1008,","journal-title":"Chem Pharm Bull"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"15925","DOI":"10.1155\/2007\/15925","volume":"2007","author":"Kostova I.","year":"2007","unstructured":"Kostova I, Momekov G, Stancheva P. Met Based Drugs, New samarium(iii), gadolinium(iii), and dysprosium(iii) complexes of coumarin-3-carboxylic acid as antiproliferative agents.,, 2007, 2007,, 15925-,","journal-title":"Met Based Drugs"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0223-5234(01)01221-1","volume":"36","author":"Kostova I.","year":"2001","unstructured":"Kostova I, Manolov I, Nicolova I, Konstantinov S, Karaivanova M. Eur J Med Chem, New lanthanide complexes of 4-methyl-7-hydroxycoumarin and their pharmacological activity.,, 2001, 36,, 339-347,","journal-title":"Eur J Med Chem"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ejmech.2004.06.002","volume":"39","author":"Kostova I.","year":"2004","unstructured":"Kostova I, Manolov I, Momekov G. Eur J Med Chem, Cytotoxic activity of new neodymium (III) complexes of bis-coumarins.,, 2004, 39,, 765-775,","journal-title":"Eur J Med Chem"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.ejmech.2005.07.010","volume":"40","author":"Kostova I.","year":"2005","unstructured":"Kostova I, Manolov I, Momekov G, Tzanova T, Konstantinov S, Karaivanova M. Eur J Med Chem, Cytotoxic activity of new cerium (III) complexes of bis-coumarins.,, 2005, 40,, 1246-1254,","journal-title":"Eur J Med Chem"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejmech.2007.03.007","volume":"43","author":"Kostova I.","year":"2008","unstructured":"Kostova I, Momekov G. Eur J Med Chem, New cerium(III) complexes of coumarins - synthesis, characterization and cytotoxicity evaluation.,, 2008, 43,, 178-188,","journal-title":"Eur J Med Chem"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ejmech.2006.03.020","volume":"41","author":"Kostova I.","year":"2006","unstructured":"Kostova I, Momekov G. Eur J Med Chem, New zirconium (IV) complexes of coumarins with cytotoxic activity.,, 2006, 41,, 717-726,","journal-title":"Eur J Med Chem"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/1521-4184(200105)334:5<157::AID-ARDP157>3.0.CO;2-S","volume":"334","author":"Kostova I.","year":"2001","unstructured":"Kostova I, Manolov I, Karaivanova M. Arch Pharm, Synthesis, physicochemical characterization, and cytotoxic screening of new zirconium complexes with coumarin derivatives.,, 2001, 334,, 157-162,","journal-title":"Arch Pharm"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.1021\/ic700861a","volume":"46","author":"Casas J.S.","year":"2007","unstructured":"Casas JS, Castellano EE, Couce MD, Crespo O, Ellena J, Laguna A, Sanchez A, Sordo J, Taboada C. Inorg Chem, Novel gold(I) 7-azacoumarin complex: Synthesis, structure, optical properties, and cytotoxic effects.,, 2007, 46,, 6236-6238,","journal-title":"Inorg Chem"},{"key":"ref=60","first-page":"439","volume":"3","author":"Batra P.","year":"2013","unstructured":"Batra P, Sharma AK. Biotech, Anti-cancer potential of flavonoids: Recent trends and future perspectives.,, 2013, 3,, 439-459,","journal-title":"Biotech"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.foodchem.2006.11.054","volume":"104","author":"Tripoli E.","year":"2007","unstructured":"Tripoli E, Guardia ML, Giammanco S, Majo DD, Giammanco M. Food Chem, Citrus flavonoids: Molecular structure, biological activity and nutritional properties: A review.,, 2007, 104,, 466-479,","journal-title":"Food Chem"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cbi.2017.06.016","volume":"273","author":"Samsonowicz M.","year":"2017","unstructured":"Samsonowicz M, Regulska E, Kalinowska M. Chem Biol Interact, Hydroxyflavone metal complexes - molecular structure, antioxidant activity and biological effects.,, 2017, 273,, 245-256,","journal-title":"Chem Biol Interact"},{"key":"ref=63","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2478\/10004-1254-62-2011-2122","volume":"62","author":"Durgo K.","year":"2011","unstructured":"Durgo K, Halec I, Sola I, Franekic J. Arhiv za higijenu rada i toksikologiju, Cytotoxic and genotoxic effects of the quercetin\/lanthanum complex on human cervical carcinoma cells in vitro.,, 2011, 62,, 221-227,","journal-title":"Arhiv za higijenu rada i toksikologiju"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.bmc.2008.11.063","volume":"17","author":"Tan J.","year":"2009","unstructured":"Tan J, Wang B, Zhu L. Bioorg Med Chem, DNA binding, cytotoxicity, apoptotic inducing activity, and molecular modeling study of quercetin zinc(II) complex.,, 2009, 17,, 614-620,","journal-title":"Bioorg Med Chem"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s10534-010-9353-x","volume":"23","author":"Tan J.","year":"2010","unstructured":"Tan J, Zhu L, Wang B. Biometals, From GC-rich DNA binding to the repression of survivin gene for quercetin nickel (II) complex: Implications for cancer therapy.,, 2010, 23,, 1075-1084,","journal-title":"Biometals"},{"key":"ref=66","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cbi.2015.06.011","volume":"239","author":"Ikeda N.E.A.","year":"2015","unstructured":"Ikeda NEA, Novak EM, Maria DA, Velosa AS, Pereira RMS. Chem Biol Interact, Synthesis, characterization and biological evaluation of Rutin\u2013zinc(II) flavonoid -metal complex.,, 2015, 239,, 184-191,","journal-title":"Chem Biol Interact"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1039\/C6MB00161K","volume":"12","author":"Roy A.S.","year":"2016","unstructured":"Roy AS, Tripathy DR, Samanta S, Ghosh SK, Dasgupta S. BioSys, DNA damaging, cell cytotoxicity and serum albumin binding efficacy of the rutin-Cu(ii) complex. Mol.,, 2016, 12,, 1687-1701,","journal-title":"BioSys"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.snb.2009.10.060","volume":"144","author":"Zhang G.","year":"2010","unstructured":"Zhang G, Guo J, Zhao N, Wang J. Sens Actuators B Chem, Study of interaction between kaempferol\u2013Eu3+ complex and DNA with the use of the neutral red dye as a fluorescence probe.,, 2010, 144,, 239-246,","journal-title":"Sens Actuators B Chem"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1155\/2014\/354138","volume":"2014","author":"Wang Q.","year":"2014","unstructured":"Wang Q, Huang Y, Zhang J-S, Yang X-B. Bioinorg Chem Appl, Synthesis, characterization, DNA interaction, and antitumor activities of la (iii) complex with schiff base ligand derived from kaempferol and diethylenetriamine.,, 2014, 2014,, 9-,","journal-title":"Bioinorg Chem Appl"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1016\/j.bmcl.2016.03.091","volume":"26","author":"Tu L-Y.","year":"2016","unstructured":"Tu L-Y, Pi J, Jin H, Cai J-Y, Deng S-P. Bioorg Med Chem Lett, Synthesis, characterization and anticancer activity of kaempferol-zinc(II) complex.,, 2016, 26,, 2730-2734,","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=71","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1039\/C6MB00344C","volume":"12","author":"Roy A.S.","year":"2016","unstructured":"Roy AS, Samanta SK, Ghosh P, Tripathy DR, Ghosh SK, Dasgupta S. Mol Biosyst, Cell cytotoxicity and serum albumin binding capacity of the morin-Cu(ii) complex and its effect on deoxyribonucleic acid.,, 2016, 12,, 2818-2833,","journal-title":"Mol Biosyst"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cbi.2013.10.006","volume":"206","author":"Naso L.G.","year":"2013","unstructured":"Naso LG, Lezama L, Rojo T, Etcheverry SB, Valcarcel M, Roura M, Salado C, Ferrer EG, Williams PA. Chem Biol Interact, Biological evaluation of morin and its new oxovanadium(IV) complex as antioxidant and specific anti-cancer agents.,, 2013, 206,, 289-301,","journal-title":"Chem Biol Interact"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10534-015-9894-0","volume":"29","author":"Tamayo L.V.","year":"2016","unstructured":"Tamayo LV, Gouvea LR, Sousa AC, Albuquerque RM, Teixeira SF, de Azevedo RA, Louro SRW, Ferreira AK, Beraldo H. Biometals, Copper(II) complexes with naringenin and hesperetin: cytotoxic activity against A 549 human lung adenocarcinoma cells and investigation on the mode of action.,, 2016, 29,, 39-52,","journal-title":"Biometals"},{"key":"ref=74","first-page":"9","volume":"2009","author":"Tan M.","year":"2009","unstructured":"Tan M, Zhu J, Pan Y, Chen Z, Liang H, Liu H, Wang H. Bioinorg Chem Appl, Synthesis, cytotoxic activity, and DNA binding properties of copper (ii) complexes with hesperetin, naringenin, and apigenin.,, 2009, 2009,, 9-,","journal-title":"Bioinorg Chem Appl"},{"key":"ref=75","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1016\/j.bmc.2005.10.031","volume":"14","author":"Wang B-D.","year":"2006","unstructured":"Wang B-D, Yang Z-Y, Wang Q, Cai T-K, Crewdson P. Bioorg Med Chem, Synthesis, characterization, cytotoxic activities, and DNA-binding properties of the La(III) complex with Naringenin Schiff-base.,, 2006, 14,, 1880-1888,","journal-title":"Bioorg Med Chem"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"107058","DOI":"10.1371\/journal.pone.0107058","volume":"9","author":"Filho J.C.C.","year":"2014","unstructured":"Filho JCC, Sarria ALF, Becceneri AB, Fuzer AM, Batalh\u00e3o JR, da Silva CMP, Carlos RM, Vieira PC, Fernandes JB, Cominetti MR. PLoS One, Copper (II) and 2,2\u2032-bipyridine complexation improves chemopreventive effects of naringenin against breast tumor cells.,, 2014, 9,, e107058-,","journal-title":"PLoS One"},{"key":"ref=77","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jinorgbio.2015.04.011","volume":"149","author":"Islas M.S.","year":"2015","unstructured":"Islas MS, Naso LG, Lezama L, Valcarcel M, Salado C, Roura-Ferrer M, Ferrer EG, Williams PAM. J Inorg Biochem, Insights into the mechanisms underlying the antitumor activity of an oxidovanadium(IV) compound with the antioxidant naringenin. Albumin binding studies.,, 2015, 149,, 12-24,","journal-title":"J Inorg Biochem"},{"key":"ref=78","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.3390\/12071352","volume":"12","author":"Pereira R.M.","year":"2007","unstructured":"Pereira RM, Andrades NE, Paulino N, Sawaya AC, Eberlin MN, Marcucci MC, Favero GM, Novak EM, Bydlowski SP. Molecules, Synthesis and characterization of a metal complex containing naringin and Cu, and its antioxidant, antimicrobial, antiinflammatory and tumor cell cytotoxicity.,, 2007, 12,, 1352-1366,","journal-title":"Molecules"},{"key":"ref=79","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jinorgbio.2013.07.038","volume":"127","author":"Spoerlein C.","year":"2013","unstructured":"Spoerlein C, Mahal K, Schmidt H, Schobert R. J Inorg Biochem, Effects of chrysin, apigenin, genistein and their homoleptic copper(II) complexes on the growth and metastatic potential of cancer cells.,, 2013, 127,, 107-115,","journal-title":"J Inorg Biochem"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2174\/156800908786241050","volume":"8","author":"Lin Y.","year":"2008","unstructured":"Lin Y, Shi R, Wang X, Shen H-M. Curr Cancer Drug Targets, Luteolin, a flavonoid with potentials for cancer prevention and therapy.,, 2008, 8,, 634-646,","journal-title":"Curr Cancer Drug Targets"},{"key":"ref=81","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jinorgbio.2016.01.021","volume":"157","author":"Naso L.G.","year":"2016","unstructured":"Naso LG, Lezama L, Valcarcel M, Salado C, Villace P, Kortazar D, Ferrer EG, Williams PA. J Inorg Biochem, Bovine serum albumin binding, antioxidant and anticancer properties of an oxidovanadium(IV) complex with luteolin.,, 2016, 157,, 80-93,","journal-title":"J Inorg Biochem"},{"key":"ref=82","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1039\/C6MT00045B","volume":"8","author":"Leon I.E.","year":"2016","unstructured":"Leon IE, Diez P, Etcheverry SB, Fuentes M. Metallomics, Deciphering the effect of an oxovanadium(iv) complex with the flavonoid chrysin (VOChrys) on intracellular cell signalling pathways in an osteosarcoma cell line.,, 2016, 8,, 739-749,","journal-title":"Metallomics"},{"key":"ref=83","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00775-015-1298-7","volume":"20","author":"Le\u00f3n I.E.","year":"2015","unstructured":"Le\u00f3n IE, Cadavid-Vargas JF, Tiscornia I, Porro V, Castelli S, Katkar P, Desideri A, Bollati-Fogolin M, Etcheverry SB. J Biol Inorg Chem, Oxidovanadium(IV) complexes with chrysin and silibinin: Anticancer activity and mechanisms of action in a human colon adenocarcinoma model.,, 2015, 20,, 1175-1191,","journal-title":"J Biol Inorg Chem"},{"key":"ref=84","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00775-010-0652-z","volume":"15","author":"Naso L.","year":"2010","unstructured":"Naso L, Ferrer EG, Lezama L, Rojo T, Etcheverry SB, Williams P. J Biol Inorg Chem, Role of oxidative stress in the antitumoral action of a new vanadyl(IV) complex with the flavonoid chrysin in two osteoblast cell lines: Relationship with the radical scavenger activity.,, 2010, 15,, 889-902,","journal-title":"J Biol Inorg Chem"},{"key":"ref=85","doi-asserted-by":"crossref","first-page":"5544","DOI":"10.1016\/j.bmcl.2013.08.055","volume":"23","author":"Yang F.","year":"2013","unstructured":"Yang F, Jin H, Pi J, Jiang J-H, Liu L, Bai H-H, Yang P-H, Cai J-Y. Bioorg Med Chem Lett, Anti-tumor activity evaluation of novel chrysin-organogermanium(IV) complex in MCF-7 cells.,, 2013, 23,, 5544-5551,","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=86","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.201600302","volume":"14","author":"Draut H.","year":"2017","unstructured":"Draut H, Rehm T, Begemann G, Schobert R. Chem. Biodiver., Antiangiogenic\nand toxic effects of genistein, usnic acid, and their copper\ncomplexes in zebrafish embryos at different developmental stages., , 2017","journal-title":"Chem Biodiver"},{"key":"ref=87","first-page":"481","volume":"12","author":"Go M.L.","year":"2005","unstructured":"Go ML, Wu X, Liu XL. Curr Med Chem, Chalcones: An update on cytotoxic and chemoprotective properties.,, 2005, 12,, 481-499,","journal-title":"Curr Med Chem"},{"key":"ref=88","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12263-011-0210-5","volume":"6","author":"Orlikova B.","year":"2011","unstructured":"Orlikova B, Tasdemir D, Golais F, Dicato M, Diederich M. Genes Nutr, Dietary chalcones with chemopreventive and chemotherapeutic potential.,, 2011, 6,, 125-147,","journal-title":"Genes Nutr"},{"key":"ref=89","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010027","volume":"19","author":"Mirossay L.","year":"2017","unstructured":"Mirossay L, Varinska L, Mojzis J. Int J Mol Sci, Antiangiogenic effect of flavonoids and chalcones: An update.,, 2017, 19,, 125-,","journal-title":"Int J Mol Sci"},{"key":"ref=90","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ejmech.2014.02.021","volume":"76","author":"El-Sayed A.M.R.","year":"2014","unstructured":"El-Sayed AMR, Fodah ARHH, Saleh SY. Eur J Med Chem, Antiobesity, antioxidant and cytotoxicity activities of newly synthesized chalcone derivatives and their metal complexes.,, 2014, 76,, 517-530,","journal-title":"Eur J Med Chem"},{"key":"ref=91","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ejmech.2013.04.036","volume":"65","author":"Da-Silva J.G.","year":"2013","unstructured":"Da-Silva JG, Despaigne RAA, Louro SR, Bandeira CC, Souza-Fagundes EM, Beraldo H. Eur J Med Chem, Cytotoxic activity, albumin and DNA binding of new copper(II) complexes with chalcone-derived thiosemicarbazones.,, 2013, 65,, 415-426,","journal-title":"Eur J Med Chem"},{"key":"ref=92","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1021\/jm801001d","volume":"52","author":"Schobert R.","year":"2009","unstructured":"Schobert R, Biersack B, Dietrich A, Knauer S, Zoldakova M, Fruehauf A, Mueller T. J Med Chem, Pt(II) complexes of a combretastatin A-4 analogous chalcone: Effects of conjugation on cytotoxicity, tumor specificity, and long-term tumor growth suppression.,, 2009, 52,, 241-246,","journal-title":"J Med Chem"},{"key":"ref=93","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00775-013-1061-x","volume":"19","author":"Leon I.E.","year":"2014","unstructured":"Leon IE, Porro V, Di Virgilio AL, Naso LG, Williams PAM, Bollati-Fogol\u00edn M, Etcheverry SB. J Biol Inorg Chem, Antiproliferative and apoptosis-inducing activity of an oxidovanadium(IV) complex with the flavonoid silibinin against osteosarcoma cells.,, 2014, 19,, 59-74,","journal-title":"J Biol Inorg Chem"},{"key":"ref=94","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.lfs.2005.12.007","volume":"78","author":"Maheshwari R.K.","year":"2006","unstructured":"Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. Life Sci, Multiple biological activities of curcumin: A short review.,, 2006, 78,, 2081-2087,","journal-title":"Life Sci"},{"key":"ref=95","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.bcp.2007.08.016","volume":"75","author":"Goel A.","year":"2008","unstructured":"Goel A, Kunnumakkara AB, Aggarwal BB. Biochem Pharmacol, Curcumin as \u201cCurecumin\u201d: From kitchen to clinic.,, 2008, 75,, 787-809,","journal-title":"Biochem Pharmacol"},{"key":"ref=96","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1002\/jcp.26055","volume":"233","author":"Mirzaei H.","year":"2018","unstructured":"Mirzaei H, Masoudifar A, Sahebkar A, Zare N, Nahand SJ, Rashidi B, Mehrabian E, Mohammadi M, Mirzaei HR, Jaafari MR. J Cell Physiol, MicroRNA: A novel target of curcumin in cancer therapy.,, 2018, 233,, 3004-3015,","journal-title":"J Cell Physiol"},{"key":"ref=97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/112_2016_3","volume":"171","author":"Momtazi A.A.","year":"2016","unstructured":"Momtazi AA, Shahabipour F, Khatibi S, Johnston TP, Pirro M, Sahebkar A. Rev Physiol Biochem Pharmacol, Curcumin as a MicroRNA regulator in cancer: A review.,, 2016, 171,, 1-38,","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"ref=98","author":"Aggarwal B.B.","unstructured":"Aggarwal BB, Surh Y-J, Shishodia S. The Molecular Targets\nand Therapeutic Uses of Curcumin in Health and Disease, , Eds.;\nSpringer US: Boston, MA, 2007, pp 1-75.,","journal-title":"The Molecular Targets\nand Therapeutic Uses of Curcumin in Health and Disease"},{"key":"ref=99","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1021\/acs.accounts.5b00127","volume":"48","author":"Banerjee S.","year":"2015","unstructured":"Banerjee S, Chakravarty AR. Acc Chem Res, Metal complexes of curcumin for cellular imaging, targeting, and photoinduced anticancer activity.,, 2015, 48,, 2075-2083,","journal-title":"Acc Chem Res"},{"key":"ref=100","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.1039\/C5CS00088B","volume":"44","author":"Wanninger S.","year":"2015","unstructured":"Wanninger S, Lorenz V, Subhan A, Edelmann FT. Chem Soc Rev, Metal complexes of curcumin - synthetic strategies, structures and medicinal applications.,, 2015, 44,, 4986-5002,","journal-title":"Chem Soc Rev"},{"key":"ref=101","doi-asserted-by":"crossref","first-page":"20091","DOI":"10.3390\/molecules191220091","volume":"19","author":"Priyadarsini K.","year":"2014","unstructured":"Priyadarsini K. Molecules, The chemistry of curcumin: From extraction to therapeutic agent.,, 2014, 19,, 20091-,","journal-title":"Molecules"},{"key":"ref=102","first-page":"2070","volume":"19","author":"Mandy H.M.L.","year":"2013","unstructured":"Mandy HML, Takaaki H, Tak WK. Curr Pharm Des, Delivery of curcumin and medicinal effects of the copper(ii)-curcumin complexes.,, 2013, 19,, 2070-2083,","journal-title":"Curr Pharm Des"},{"key":"ref=103","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s11243-014-9831-z","volume":"39","author":"Wang J.","year":"2014","unstructured":"Wang J, Wei D, Jiang B, Liu T, Ni J, Zhou S. Trans Met Chem, Two copper(II) complexes of curcumin derivatives: Synthesis, crystal structure and in vitro antitumor activity.,, 2014, 39,, 553-558,","journal-title":"Trans Met Chem"},{"key":"ref=104","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1007\/s11095-009-9900-8","volume":"26","author":"Padhye S.","year":"2009","unstructured":"Padhye S, Yang H, Jamadar A, Cui QC, Chavan D, Dominiak K, McKinney J, Banerjee S, Dou QP, Sarkar FH. Pharm Res, New difluoro knoevenagel condensates of curcumin, their schiff bases and copper complexes as proteasome inhibitors and apoptosis inducers in cancer cells.,, 2009, 26,, 1874-1880,","journal-title":"Pharm Res"},{"key":"ref=105","first-page":"219","volume":"21","author":"John V.D.","year":"2002","unstructured":"John VD, Kuttan G, Krishnankutty K. J Exp Clin Cancer Res, Anti-tumour studies of metal chelates of synthetic curcuminoids.,, 2002, 21,, 219-224,","journal-title":"J Exp Clin Cancer Res"},{"key":"ref=106","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/aoc.1089","volume":"20","author":"John V.D.","year":"2006","unstructured":"John VD, Krishnankutty K. Appl Organomet Chem, Antitumour activity of synthetic curcuminoid analogues (1,7-diaryl-1,6-heptadiene-3,5-diones) and their copper complexes.,, 2006, 20,, 477-482,","journal-title":"Appl Organomet Chem"},{"key":"ref=107","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nrc1071","volume":"3","author":"Dolmans D.E.J.G.J.","year":"2003","unstructured":"Dolmans DEJGJ, Fukumura D, Jain RK. Nat Rev Cancer, Photodynamic therapy for cancer.,, 2003, 3,, 380-387,","journal-title":"Nat Rev Cancer"},{"key":"ref=108","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ejmech.2013.03.026","volume":"63","author":"Goswami T.K.","year":"2013","unstructured":"Goswami TK, Gadadhar S, Gole B, Karande AA, Chakravarty AR. Eur J Med Chem, Photocytotoxicity of copper(II) complexes of curcumin and N-ferrocenylmethyl-l-amino acids.,, 2013, 63,, 800-810,","journal-title":"Eur J Med Chem"},{"key":"ref=109","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/j.jinorgbio.2004.09.011","volume":"98","author":"Thompson K.H.","year":"2004","unstructured":"Thompson KH, B\u00f6hmerle K, Polishchuk E, Martins C, Toleikis P, Tse J, Yuen V, McNeill JH, Orvig C. J Inorg Biochem, Complementary inhibition of synoviocyte, smooth muscle cell or mouse lymphoma cell proliferation by a vanadyl curcumin complex compared to curcumin alone.,, 2004, 98,, 2063-2070,","journal-title":"J Inorg Biochem"},{"key":"ref=110","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/j.jinorgbio.2005.08.001","volume":"99","author":"Mohammadi K.","year":"2005","unstructured":"Mohammadi K, Thompson KH, Patrick BO, Storr T, Martins C, Polishchuk E, Yuen VG, McNeill JH, Orvig C. J Inorg Biochem, Synthesis and characterization of dual function vanadyl, gallium and indium curcumin complexes for medicinal applications.,, 2005, 99,, 2217-2225,","journal-title":"J Inorg Biochem"},{"key":"ref=111","first-page":"1","author":"Hamidi A.","year":"2015","unstructured":"Hamidi A, Hassani L, Mohammadi F, Jahangoshayi P, Mohammadi K. J Enzyme Inhib Med Chem, The biological effects of vanadyl curcumin and vanadyl diacetylcurcumin complexes: The effect on structure, function and oxidative stability of the peroxidase enzyme, antibacterial activity and cytotoxic effect.,, 2015, 99,, 1-8,","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=112","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ejmech.2014.07.098","volume":"85","author":"Balaji B.","year":"2014","unstructured":"Balaji B, Balakrishnan B, Perumalla S, Karande AA, Chakravarty AR. Eur J Med Chem, Photoactivated cytotoxicity of ferrocenyl-terpyridine oxovanadium(IV) complexes of curcuminoids.,, 2014, 85,, 458-467,","journal-title":"Eur J Med Chem"},{"key":"ref=113","doi-asserted-by":"crossref","first-page":"13358","DOI":"10.1039\/C4DT01487A","volume":"43","author":"Banik B.","year":"2014","unstructured":"Banik B, Somyajit K, Nagaraju G, Chakravarty AR. Dalton Trans, Oxovanadium(iv) complexes of curcumin for cellular imaging and mitochondria targeted photocytotoxicity.,, 2014, 43,, 13358-13369,","journal-title":"Dalton Trans"},{"key":"ref=114","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1039\/c2md00261b","volume":"3","author":"Pucci D.","year":"2012","unstructured":"Pucci D, Bellini T, Crispini A, D\u2019Agnano I, Liguori PF, Garcia-Orduna P, Pirillo S, Valentini A, Zanchetta G. MedChemComm, DNA binding and cytotoxicity of fluorescent curcumin-based Zn(ii) complexes.,, 2012, 3,, 462-468,","journal-title":"MedChemComm"},{"key":"ref=115","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/cddis.2014.217","volume":"5","author":"Garufi A.","year":"2014","unstructured":"Garufi A, Pucci D, D\u2019Orazi V, Cirone M, Bossi G, Avantaggiati ML, D\u2019Orazi G. Cell Death Dis, Degradation of mutant p53H175 protein by Zn(II) through autophagy.,, 2014, 5,, e1271-,","journal-title":"Cell Death Dis"},{"key":"ref=116","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1756-9966-32-72","volume":"32","author":"Garufi A.","year":"2013","unstructured":"Garufi A, Trisciuoglio D, Porru M, Leonetti C, Stoppacciaro A, D\u2019Orazi V, Avantaggiati ML, Crispini A, Pucci D, D\u2019Orazi G. J Exp Clin Cancer Res, A fluorescent curcumin-based Zn(II)-complex reactivates mutant (R175H and R273H) p53 in cancer cells.,, 2013, 32,, 72-,","journal-title":"J Exp Clin Cancer Res"},{"key":"ref=117","doi-asserted-by":"crossref","first-page":"69884","DOI":"10.1371\/journal.pone.0069884","volume":"8","author":"Botchkina G.I.","year":"2013","unstructured":"Botchkina GI, Zuniga ES, Rowehl RH, Park R, Bhalla R, Bialkowska AB, Johnson F, Golub LM, Zhang Y, Ojima I, Shroyer KR. PLoS One, Prostate cancer stem cell-targeted efficacy of a new-generation taxoid, SBT-1214 and novel polyenolic zinc-binding curcuminoid, CMC2.24.,, 2013, 8,, e69884-,","journal-title":"PLoS One"},{"key":"ref=118","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1021\/jm200912j","volume":"55","author":"Caruso F.","year":"2012","unstructured":"Caruso F, Rossi M, Benson A, Opazo C, Freedman D, Monti E, Gariboldi MB, Shaulky J, Marchetti F, Pettinari R, Pettinari C. J Med Chem, Ruthenium-arene complexes of curcumin: x-ray and density functional theory structure, synthesis, and spectroscopic characterization, in vitro antitumor activity, and DNA docking studies of (p-cymene) ru (curcuminato)chloro.,, 2012, 55,, 1072-1081,","journal-title":"J Med Chem"},{"key":"ref=119","author":"Caruso F.","year":"2016","unstructured":"Caruso F, Pettinari R, Rossi M, Monti E, Gariboldi MB, Marchetti F, Pettinari C, Caruso A, Ramani MV, Subbaraju GV. J Inorg Biochem, The in vitro antitumor activity of arene-ruthenium(II) curcuminoid complexes improves when decreasing curcumin polarity.,, 2016, 55,, 1072-,","journal-title":"J Inorg Biochem"},{"key":"ref=120","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1002\/cmdc.201200341","volume":"7","author":"Bonfili L.","year":"2012","unstructured":"Bonfili L, Pettinari R, Cuccioloni M, Cecarini V, Mozzicafreddo M, Angeletti M, Lupidi G, Marchetti F, Pettinari C, Eleuteri AM. ChemMedChem, Arene\u2013RuII complexes of curcumin exert antitumor activity via proteasome inhibition and apoptosis induction.,, 2012, 7,, 2010-2020,","journal-title":"ChemMedChem"},{"key":"ref=121","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1021\/jm801276a","volume":"52","author":"Valentini A.","year":"2009","unstructured":"Valentini A, Conforti F, Crispini A, De Martino A, Condello R, Stellitano C, Rotilio G, Ghedini M, Federici G, Bernardini S, Pucci D. J Med Chem, Synthesis, oxidant properties, and antitumoral effects of a heteroleptic palladium(ii) complex of curcumin on human prostate cancer cells.,, 2009, 52,, 484-491,","journal-title":"J Med Chem"},{"key":"ref=122","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1039\/C2DT32042H","volume":"42","author":"Hussain A.","year":"2013","unstructured":"Hussain A, Somyajit K, Banik B, Banerjee S, Nagaraju G, Chakravarty AR. Dalton Trans, Enhancing the photocytotoxic potential of curcumin on terpyridyl lanthanide(iii) complex formation.,, 2013, 42,, 182-195,","journal-title":"Dalton Trans"},{"key":"ref=123","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jinorgbio.2008.12.001","volume":"103","author":"Song Y-M.","year":"2009","unstructured":"Song Y-M, Xu J-P, Ding L, Hou Q, Liu J-W, Zhu Z-L. J Inorg Biochem, Syntheses, characterization and biological activities of rare earth metal complexes with curcumin and 1,10-phenanthroline-5,6-dione.,, 2009, 103,, 396-400,","journal-title":"J Inorg Biochem"},{"key":"ref=124","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1021\/ic403113z","volume":"53","author":"Asti M.","year":"2014","unstructured":"Asti M, Ferrari E, Croci S, Atti G, Rubagotti S, Iori M, Capponi PC, Zerbini A, Saladini M, Versari A. Inorg Chem, Synthesis and characterization of 68Ga-labeled curcumin and curcuminoid complexes as potential radiotracers for imaging of cancer and alzheimer\u2019s disease.,, 2014, 53,, 4922-4933,","journal-title":"Inorg Chem"},{"key":"ref=125","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2174\/9781681081496115060007","volume":"6","author":"de las-Heras B.","year":"2015","unstructured":"de las-Heras B, Hortelano S. Anti-cancer Drug Discov, Terpenoids in cancer: Molecular targets and clinical perspectives. Fron.,, 2015, 6,, 137-195,","journal-title":"Anti-cancer Drug Discov"},{"key":"ref=126","doi-asserted-by":"crossref","first-page":"6876","DOI":"10.1021\/jo00051a037","volume":"57","author":"McMorris T.C.","year":"1992","unstructured":"McMorris TC, Kelner MJ, Wang W, Estes LA, Montoya MA, Taetle R. J Org Chem, Structure-activity relationships of illudins: Analogs with improved therapeutic index.,, 1992, 57,, 6876-6883,","journal-title":"J Org Chem"},{"key":"ref=127","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s002800050627","volume":"40","author":"Kelner M.J.","year":"1997","unstructured":"Kelner MJ, McMorris TC, Montoya MA, Estes L, Rutherford M, Samson KM, Taetle R. Cancer Chemother Pharmacol, Characterization of cellular accumulation and toxicity of illudin S in sensitive and nonsensitive tumor cells.,, 1997, 40,, 65-71,","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref=128","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/CAD.0b013e32832e056a","volume":"20","author":"Knauer S.","year":"2009","unstructured":"Knauer S, Biersack B, Zoldakova M, Effenberger K, Milius W, Schobert R. Anticancer Drugs, Melanoma-specific ferrocene esters of the fungal cytotoxin illudin M.,, 2009, 20,, 676-681,","journal-title":"Anticancer Drugs"},{"key":"ref=129","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm200359n","volume":"54","author":"Schobert R.","year":"2011","unstructured":"Schobert R, Seibt S, Mahal K, Ahmad A, Biersack B, Effenberger-Neidnicht K, Padhye S, Sarkar FH, Mueller T. J Med Chem, Cancer selective metallocenedicarboxylates of the fungal cytotoxin illudin M.,, 2011, 54,, 6177-6182,","journal-title":"J Med Chem"},{"key":"ref=130","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1021\/ja00738a045","volume":"93","author":"Wani M.C.","year":"1971","unstructured":"Wani MC, Taylor HL, Wall ME, Coggon P, McPhail AT. J Am Chem Soc, Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus Brevifolia.,, 1971, 93,, 2325-2327,","journal-title":"J Am Chem Soc"},{"key":"ref=131","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1387-7003(99)00152-5","volume":"2","author":"Murugkar A.","year":"1999","unstructured":"Murugkar A, Padhye S, Guha-Roy S, Wagh U. Inorg Chem Commun, Metal complexes of Taxol precursor: Synthesis, characterization and antitumor activity of the copper complex of 10-deacetylbaccatin thiosemicarbazone.,, 1999, 2,, 545-548,","journal-title":"Inorg Chem Commun"},{"key":"ref=132","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1021\/acs.chemrev.5b00597","volume":"116","author":"Johnstone T.C.","year":"2016","unstructured":"Johnstone TC, Suntharalingam K, Lippard SJ. Chem Rev, The next generation of platinum drugs: Targeted Pt(II) agents, nanoparticle delivery, and pt(IV) Prodrugs.,, 2016, 116,, 3436-3486,","journal-title":"Chem Rev"},{"key":"ref=133","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1021\/ic010152a","volume":"40","author":"Jackson A.","year":"2001","unstructured":"Jackson A, Davis J, Pither RJ, Rodger A, Hannon MJ. Inorg Chem, Estrogen-derived steroidal metal complexes:\u2009Agents for cellular delivery of metal centers to estrogen receptor-positive cells.,, 2001, 40,, 3964-3973,","journal-title":"Inorg Chem"},{"key":"ref=134","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.steroids.2008.04.009","volume":"73","author":"Descoteaux C.","year":"2008","unstructured":"Descoteaux C, Leblanc V, Belanger G, Parent S, Asselin E, Berube G. Steroids, Improved synthesis of unique estradiol-linked platinum(II) complexes showing potent cytocidal activity and affinity for the estrogen receptor alpha and beta.,, 2008, 73,, 1077-1089,","journal-title":"Steroids"},{"key":"ref=135","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.bmcl.2008.03.005","volume":"18","author":"Provencher-Mandeville J.","year":"2008","unstructured":"Provencher-Mandeville J, Descoteaux C, Mandal SK, Leblanc V, Asselin E, Berube G. Bioorg Med Chem Lett, Synthesis of 17beta-estradiol-platinum(II) hybrid molecules showing cytotoxic activity on breast cancer cell lines.,, 2008, 18,, 2282-2287,","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=136","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.steroids.2010.09.004","volume":"76","author":"Provencher-Mandeville J.","year":"2011","unstructured":"Provencher-Mandeville J, Debnath C, Mandal SK, Leblanc V, Parent S, Asselin \u00c9, B\u00e9rub\u00e9 G. Steroids, Design, synthesis and biological evaluation of estradiol-PEG-linked platinum(II) hybrid molecules: Comparative molecular modeling study of three distinct families of hybrids.,, 2011, 76,, 94-103,","journal-title":"Steroids"},{"key":"ref=137","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jinorgbio.2013.07.010","volume":"128","author":"Zamora A.","year":"2013","unstructured":"Zamora A, Rodriguez V, Cutillas N, Yellol GS, Espinosa A, Samper KG, Capdevila M, Palacios O, Ruiz J. J Inorg Biochem, New steroidal 7-azaindole platinum(II) antitumor complexes.,, 2013, 128,, 48-56,","journal-title":"J Inorg Biochem"},{"key":"ref=138","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1016\/j.bmc.2012.10.013","volume":"20","author":"Kvasnica M.","year":"2012","unstructured":"Kvasnica M, Rarova L, Oklestkova J, Budesinsky M, Kohout L. Bioorg Med Chem, Synthesis and cytotoxic activities of estrone and estradiol cis-dichloroplatinum(II) complexes.,, 2012, 20,, 6969-6978,","journal-title":"Bioorg Med Chem"},{"key":"ref=139","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ejmech.2011.12.017","volume":"48","author":"Saha P.","year":"2012","unstructured":"Saha P, Descoteaux C, Brasseur K, Fortin S, Leblanc V, Parent S, Asselin E, Berube G. Eur J Med Chem, Synthesis, antiproliferative activity and estrogen receptor alpha affinity of novel estradiol-linked platinum(II) complex analogs to carboplatin and oxaliplatin. Potential vector complexes to target estrogen-dependent tissues.,, 2012, 48,, 385-390,","journal-title":"Eur J Med Chem"},{"key":"ref=140","doi-asserted-by":"crossref","first-page":"9164","DOI":"10.1021\/ic201388n","volume":"50","author":"Ruiz J.","year":"2011","unstructured":"Ruiz J, Rodriguez V, Cutillas N, Espinosa A, Hannon MJ. Inorg Chem, A potent ruthenium(II) antitumor complex bearing a lipophilic levonorgestrel group.,, 2011, 50,, 9164-9171,","journal-title":"Inorg Chem"},{"key":"ref=141","doi-asserted-by":"crossref","first-page":"12847","DOI":"10.1039\/c2dt31654d","volume":"41","author":"Ruiz J.","year":"2012","unstructured":"Ruiz J, Rodriguez V, Cutillas N, Samper KG, Capdevila M, Palacios O, Espinosa A, Novel C. Dalton Trans, N-chelate rhodium(III) and iridium(III) antitumor complexes incorporating a lipophilic steroidal conjugate and their interaction with DNA.,, 2012, 41,, 12847-12856,","journal-title":"Dalton Trans"},{"key":"ref=142","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.steroids.2010.12.009","volume":"76","author":"Schobert R.","year":"2011","unstructured":"Schobert R, Seibt S, Effenberger-Neidnicht K, Underhill C, Biersack B, Hammond GL. Steroids, (Arene)Cl2Ru(II) complexes with N-coordinated estrogen and androgen isonicotinates: Interaction with sex hormone binding globulin and anticancer activity.,, 2011, 76,, 393-399,","journal-title":"Steroids"},{"key":"ref=143","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ejmech.2013.08.011","volume":"68","author":"Fortin S.","year":"2013","unstructured":"Fortin S, Brasseur K, Morin N, Asselin E, Berube G. Eur J Med Chem, New platinum(II) complexes conjugated at position 7alpha of 17beta-acetyl-testosterone as new combi-molecules against prostate cancer: Design, synthesis, structure-activity relationships and biological evaluation.,, 2013, 68,, 433-443,","journal-title":"Eur J Med Chem"},{"key":"ref=144","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1155\/MBD.1999.177","volume":"6","author":"Murugkar A.","year":"1999","unstructured":"Murugkar A, Unnikrishnan B, Padhye S, Bhonde R, Teat S, Triantafillou E, Sinn E. Met Based Drugs, Hormone anchored metal complexes. Synthesis, structure, spectroscopy and in vitro antitumor activity of testosterone acetate thiosemicarbazone and its metal complexes.,, 1999, 6,, 177-182,","journal-title":"Met Based Drugs"},{"key":"ref=145","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1021\/om800698y","volume":"28","author":"Top S.","year":"2009","unstructured":"Top S, Thibaudeau C, Vessi\u00e8res A, Brul\u00e9 E, Le Bideau F, Joerger J-M, Plamont M-A, Samreth S, Edgar A, Marrot J, Herson P, Jaouen G. Organometallics, Synthesis and structure activity relationship of organometallic steroidal androgen derivatives.,, 2009, 28,, 1414-1424,","journal-title":"Organometallics"},{"key":"ref=146","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.bmcl.2009.11.128","volume":"20","author":"Adsule S.","year":"2010","unstructured":"Adsule S, Banerjee S, Ahmed F, Padhye S, Sarkar FH. Bioorg Med Chem Lett, Hybrid anticancer agents: Isothiocyanate\u2013progesterone conjugates as chemotherapeutic agents and insights into their cytotoxicities.,, 2010, 20,, 1247-1251,","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=147","first-page":"12","volume":"2012","author":"Lu J-J.","year":"2012","unstructured":"Lu J-J, Bao J-L, Chen X-P, Huang M, Wang Y-T. Evid Based Comp Alter Med, Alkaloids Isolated from natural herbs as the anticancer agents.,, 2012, 2012,, 12-,","journal-title":"Evid Based Comp Alter Med"},{"key":"ref=148","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1021\/ic200443p","volume":"51","author":"Chen Z-F.","year":"2012","unstructured":"Chen Z-F, Shi Y-F, Liu Y-C, Hong X, Geng B, Peng Y, Liang H. Inorg Chem, TCM active ingredient oxoglaucine metal complexes: Crystal structure, cytotoxicity, and interaction with DNA.,, 2012, 51,, 1998-2009,","journal-title":"Inorg Chem"},{"key":"ref=149","doi-asserted-by":"crossref","first-page":"11408","DOI":"10.1039\/C5DT00926J","volume":"44","author":"Wei J.H.","year":"2015","unstructured":"Wei JH, Chen ZF, Qin JL, Liu YC, Li ZQ, Khan TM, Wang M, Jiang YH, Shen WY, Liang H. Dalton Trans, Water-soluble oxoglaucine-Y(III), Dy(III) complexes: In vitro and in vivo anticancer activities by triggering DNA damage, leading to S phase arrest and apoptosis.,, 2015, 44,, 11408-11419,","journal-title":"Dalton Trans"},{"key":"ref=150","first-page":"531","volume":"34","author":"Liu Y.C.","year":"2014","unstructured":"Liu YC, Chen ZF, Shi YF, Huang KB, Geng B, Liang H. Anticancer Res, Oxoglaucine-lanthanide complexes: Synthesis, crystal structure and cytotoxicity.,, 2014, 34,, 531-536,","journal-title":"Anticancer Res"},{"key":"ref=151","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0040-4020(61)80085-9","volume":"14","author":"Taylor W.I.","year":"1961","unstructured":"Taylor WI. Tetrahedron, The structure and synthesis of liriodenine, a new type of isoquinoline alkaloid.,, 1961, 14,, 42-45,","journal-title":"Tetrahedron"},{"key":"ref=152","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jinorgbio.2014.04.001","volume":"137","author":"Li Y.L.","year":"2014","unstructured":"Li YL, Qin QP, Liu YC, Chen ZF, Liang H. J Inorg Biochem, A platinum(II) complex of liriodenine from Traditional Chinese Medicine (TCM): Cell cycle arrest, cell apoptosis induction and telomerase inhibition activity via G-quadruplex DNA stabilization.,, 2014, 137,, 12-21,","journal-title":"J Inorg Biochem"},{"key":"ref=153","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s00216-002-1675-2","volume":"375","author":"Lai J.P.","year":"2003","unstructured":"Lai JP, He XW, Jiang Y, Chen F. Anal Bioanal Chem, Preparative separation and determination of matrine from the chinese medicinal plant Sophora flavescens ait by molecularly imprinted solid-phase extraction.,, 2003, 375,, 264-269,","journal-title":"Anal Bioanal Chem"},{"key":"ref=154","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jep.2009.02.022","volume":"123","author":"Dai Z.J.","year":"2009","unstructured":"Dai ZJ, Gao J, Ji ZZ, Wang XJ, Ren HT, Liu XX, Wu WY, Kang HF, Guan HT. J Ethnopharmacol, Matrine induces apoptosis in gastric carcinoma cells via alteration of Fas\/FasL and activation of caspase-3.,, 2009, 123,, 91-96,","journal-title":"J Ethnopharmacol"},{"key":"ref=155","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00280-011-1699-4","volume":"69","author":"Liang C.Z.","year":"2012","unstructured":"Liang CZ, Zhang JK, Shi Z, Liu B, Shen CQ, Tao HM. Cancer Chemother Pharmacol, Matrine induces caspase-dependent apoptosis in human osteosarcoma cells in vitro and in vivo through the upregulation of Bax and Fas\/FasL and downregulation of Bcl-2.,, 2012, 69,, 317-331,","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref=156","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1248\/bpb.33.1740","volume":"33","author":"Liu T.","year":"2010","unstructured":"Liu T, Song Y, Chen H, Pan S, Sun X. Biol Pharm Bull, Matrine inhibits proliferation and induces apoptosis of pancreatic cancer cells in vitro and in vivo.,, 2010, 33,, 1740-1745,","journal-title":"Biol Pharm Bull"},{"key":"ref=157","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3892\/mmr.2012.744","volume":"5","author":"Zhang P.","year":"2012","unstructured":"Zhang P, Wang Z, Chong T, Ji Z. Mol Med Rep, Matrine inhibits proliferation and induces apoptosis of the androgenindependent prostate cancer cell line PC-3.,, 2012, 5,, 783-787,","journal-title":"Mol Med Rep"},{"key":"ref=158","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jinorgbio.2010.10.007","volume":"105","author":"Chen Z.F.","year":"2011","unstructured":"Chen ZF, Mao L, Liu LM, Liu YC, Peng Y, Hong X, Wang HH, Liu HG, Liang H. J Inorg Biochem, Potential new inorganic antitumour agents from combining the anticancer Traditional Chinese Medicine (TCM) matrine with Ga(III), Au(III), Sn(IV) ions, and DNA binding studies.,, 2011, 105,, 171-180,","journal-title":"J Inorg Biochem"},{"key":"ref=159","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinorgbio.2014.06.019","volume":"140","author":"Khan A.R.","year":"2014","unstructured":"Khan AR, Al-Farhan K, de Almeida A, Alsalme A, Casini A, Ghazzali M, Reedijk J. J Inorg Biochem, Light-stable bis(norharmane)silver(I) compounds: Synthesis, characterization and antiproliferative effects in cancer cells.,, 2014, 140,, 1-5,","journal-title":"J Inorg Biochem"},{"key":"ref=160","author":"Khan R.A.","year":"2016","unstructured":"Khan RA, de Almeida A, Al-Farhan K, Alsalme A, Casini A, Ghazzali M, Reedijk J. J Inorg Biochem, Transition-metal norharmane compounds as possible cytotoxic agents: New insights based on a coordination chemistry perspective.,, 2016, 140,, 1-,","journal-title":"J Inorg Biochem"},{"key":"ref=161","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.1039\/C4DT03679D","volume":"44","author":"Mohamed H.A.","year":"2015","unstructured":"Mohamed HA, Lake BR, Laing T, Phillips RM, Willans CE. Dalton Trans, Synthesis and anticancer activity of silver(I)-N-heterocyclic carbene complexes derived from the natural xanthine products caffeine, theophylline and theobromine.,, 2015, 44,, 7563-7569,","journal-title":"Dalton Trans"},{"key":"ref=162","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.saa.2014.03.114","volume":"138","author":"Emam S.M.","year":"2015","unstructured":"Emam SM, El Sayed Iel T, Nassar N. Mol Biomol Spect, Transition metal complexes of neocryptolepine analogues. Part I: Synthesis, spectroscopic characterization, and in vitro anticancer activity of copper(II) complexes.,, 2015, 138,, 942-953,","journal-title":"Mol Biomol Spect"}],"container-title":["Anti-Cancer Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/161467","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T03:33:53Z","timestamp":1563334433000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/161467\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,8]]},"references-count":162,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,5,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871520618666180420165821","relation":{},"ISSN":["1871-5206"],"issn-type":[{"value":"1871-5206","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2017-06-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-03-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-03-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}